Cigna Investments’s Zai Lab ZLAB Stock Holding History

Cigna Investments’s Portfolio ZLAB Stock Details ZLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,320	Closed	-$234K	–	770
2021 Q2	$234K	Buy	+1,320	New	+$212K	0.02%	660

Other funds holding ZLAB

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BAM

Brilliance Asset Management Admiralty, Hong Kong, Hong Kong $339M AUM 9.81% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Cigna Investments's ZLAB Position: Q3 2021 in Review

Cigna Investments sold out of Zai Lab (ZLAB) in Q3 2021, closing a stake of 1,320 shares — an estimated $234K sold.

Cigna Investments first reported a position in ZLAB in Q2 2021 and held it in 1 quarter. The position peaked at $234K in Q2 2021. 227 funds tracked by Wall St. Rank hold ZLAB as of Q3 2021.

Cigna Investments reported no remaining Zai Lab position as of Q3 2021 after selling out during the quarter.
Cigna Investments sold 1,320 Zai Lab shares in Q3 2021, an estimated $234K.
Cigna Investments first reported a position in Zai Lab in Q2 2021 and held it in 1 quarter.
Cigna Investments's Zai Lab position peaked at $234K in Q2 2021.
227 funds tracked by Wall St. Rank held Zai Lab as of Q3 2021.

Based on Cigna Investments's 13F filing for Q3 2021, filed 12 Nov 2021.